Type 2 Diabetes: Boehringer Ingelheim India and Lupin Announce Strategic Co-marketing Agreement – Lupin
Lupin to market Empagliflozin under the brand name Gibtulio® in India Mumbai: Boehringer Ingelheim and pharma major Lupin Limited (Lupin) today announced another strategic alliance to co-market Empagliflozin, a novel…